These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 12599554

  • 1. [PSA density, PSATZ, PSA velocity and PSA doubling time].
    Tochigi T, Kawamura S, Kuwahara M.
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():107-11. PubMed ID: 12599554
    [No Abstract] [Full Text] [Related]

  • 2. [PSA density, PSA velocity and PSA doubling time].
    Kurokawa K.
    Nihon Rinsho; 2000 Jul; 58 Suppl():103-7. PubMed ID: 11022694
    [No Abstract] [Full Text] [Related]

  • 3. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
    Wymenga LF, Mensink HJ.
    Ned Tijdschr Geneeskd; 1999 Aug 21; 143(34):1733-8. PubMed ID: 10494319
    [Abstract] [Full Text] [Related]

  • 4. [PSA follow-up after radical prostatectomy].
    Egawa S, Baba S.
    Nihon Rinsho; 2002 Dec 21; 60 Suppl 11():284-8. PubMed ID: 12599586
    [No Abstract] [Full Text] [Related]

  • 5. [Serum and urinary PSA in the diagnosis of PSA failure after radical prostatectomy].
    Arai Y, Okubo K.
    Nihon Rinsho; 2000 Jul 21; 58 Suppl():357-61. PubMed ID: 11022749
    [No Abstract] [Full Text] [Related]

  • 6. [Prostate specific antigen doubling time in prostate cancer before treatment and in refractory status].
    Nakata S, Takezawa Y, Kobayashi M, Kuribara H, Matumoto K, Kosaku N, Suzuki T, Yamanaka H.
    Nihon Rinsho; 1998 Aug 21; 56(8):2026-30. PubMed ID: 9750501
    [Abstract] [Full Text] [Related]

  • 7. Pro PSA : a "pro cancer" form of PSA?
    Peyromaure M, Fulla Y, Debré B, Dinh-Xuan AT.
    Med Hypotheses; 2005 Aug 21; 64(1):92-5. PubMed ID: 15533620
    [Abstract] [Full Text] [Related]

  • 8. The utility of PSA doubling time to monitor prostate cancer recurrence.
    Wieder JA, Belldegrun AS.
    Mayo Clin Proc; 2001 Jun 21; 76(6):571-2. PubMed ID: 11393493
    [No Abstract] [Full Text] [Related]

  • 9. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
    Aksoy Y, Oral A, Aksoy H, Demirel A, Akcay F.
    Ann Clin Lab Sci; 2003 Jun 21; 33(3):320-3. PubMed ID: 12956448
    [Abstract] [Full Text] [Related]

  • 10. [Prostate cancer].
    Uchida K, Akaza H.
    Gan To Kagaku Ryoho; 2001 Oct 21; 28(10):1469-74. PubMed ID: 11681260
    [Abstract] [Full Text] [Related]

  • 11. [Elevated PSA--what to do?].
    Machemer H, Rohde D.
    MMW Fortschr Med; 2008 Oct 30; 150(44):38-9. PubMed ID: 19024490
    [No Abstract] [Full Text] [Related]

  • 12. [Rising Prostate Specific Antigen following treatment with curative intention].
    Jakobsen H, Pedersen KV.
    Ugeskr Laeger; 2007 May 14; 169(20):1907-9. PubMed ID: 17553369
    [Abstract] [Full Text] [Related]

  • 13. [Tumor markers in prostate cancer].
    Kuriyama M.
    Gan To Kagaku Ryoho; 1994 Sep 14; 21(12):1915-22. PubMed ID: 7521999
    [Abstract] [Full Text] [Related]

  • 14. [The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].
    Stamey TA.
    Urologe A; 1990 Mar 14; 29(2):52-64. PubMed ID: 1691883
    [Abstract] [Full Text] [Related]

  • 15. [The usefulness of prostate-specific antigen assay for the early detection and follow up of the prostate cancer].
    Saito Y.
    Nihon Rinsho; 1998 Aug 14; 56(8):1989-93. PubMed ID: 9750493
    [Abstract] [Full Text] [Related]

  • 16. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H, Koide T, Kuriyama M, Ban Y, Deguchi T, Kawada Y.
    Hinyokika Kiyo; 1999 Jul 14; 45(7):457-61. PubMed ID: 10466060
    [Abstract] [Full Text] [Related]

  • 17. [The evaluation of the ratio of free and total serum prostate-specific antigen as an additional method in the diagnosis of prostatic cancer].
    Reznikov IuP, Mazanov GP, Sedova TN.
    Urol Nefrol (Mosk); 1996 Jul 14; (6):41-3. PubMed ID: 9036610
    [Abstract] [Full Text] [Related]

  • 18. [Prostate-specific antigen and its related parameters in detecting prostate cancer].
    Kuruma H, Egawa S.
    Gan To Kagaku Ryoho; 2003 Jan 14; 30(1):11-5. PubMed ID: 12557698
    [Abstract] [Full Text] [Related]

  • 19. PSA doubling time as a predictive factor on repeat biopsy for detection of prostate cancer.
    Shimbo M, Tomioka S, Sasaki M, Shima T, Suzuki N, Murakami S, Nakatsu H, Shimazaki J.
    Jpn J Clin Oncol; 2009 Nov 14; 39(11):727-31. PubMed ID: 19674994
    [Abstract] [Full Text] [Related]

  • 20. Study supports PSA velocity risk count.
    Fillon M.
    J Natl Cancer Inst; 2012 Jul 18; 104(14):1042-3. PubMed ID: 22781432
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.